ANG Lifesciences India Share Price

CMP as on13-Aug-20 12:32

₹ 41.50
1.5 3.75%

Open

₹ 42.40

Turnover (lac)

₹ 1

Prev. Close

₹ 40.00

Day's Vol (shares)

₹ 4,800

Day's Range

₹ 41.25
₹ 42.40

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 22-Jun-2020 - -
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the half year and Financial Year ended March 31, 2020. 2. to appoint Mr. Subodh Sharma as Chief Financial Officer of the Company. 3. To consider and approve any other matter with permission of Board. Further, we wish to inform you that in accordance with the provisions of the Companys Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015 to regulate, monitor and report trading by insiders, the Trading Window for trading in the Equity Shares of the Company was closed from 1st April, 2020 and shall reopen on 3rd July, 2020. The Board Meeting to be held on 30/06/2020 Stands Cancelled. (As Per BSE Announcement Dated on 29-06-2020) Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors in its meeting held on July 21, 2020 has inter-alia: 1. Considered and approved the Standalone Audited Financial Results of the Company for the half year and financial year ended March 31, 2020 along with the Auditors Report thereon received from M/s Ajay K. Khanna & Co., Statutory Auditors of the Company and declaration pursuant to Reg. 33(3)(d) of Listing Regulations. 2. Appointed Mr. Subodh Sharma as Chief Financial Officer & Key Managerial Personnel of the Company with immediate effect. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith: 1. Audited Financial Results of the Company for the half year and financial year ended March 31, 2020 as approved in the Board of Directors Meeting held today, along with the Auditors Report thereon received from M/s Ajay K. Khanna & Co., Statutory Auditors of the Company. 2. Declaration pursuant to Reg. 33(3)(d) of Listing Regulations. Kindly take this information on your record. (AS Per BSE Announcement Dated on 21.07.2020) Pursuant to Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, it is hereby informed that the Board of Directors in its meeting held on 21.07.2020 has appointed Mr. Subodh Sharma as Chief Financial Officer & Key Managerial Personnel of the Company with immediate effect. (As Per BSE Announcement dated on 22.07.2020)
Board Meeting - 06-Nov-2019 - -
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the half year ended September 30, 2019. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Un-Audited Financial Results of the Company for the Half Year ended September 30, 2019 and the Statement of Assets and Liabilities as at September 30, 2019 as approved by Board of Directors in its meeting held on November 14, 2019 along with the Limited Review Report issued by M/s Ajay K Khanna & Co., Statutory Auditors of the Company. Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors in its meeting held on November 14, 2019 has considered and approved the Standalone Un-Audited Financial Results of the Company for the Half year ended September 30, 2019 along with Statement of Assets and Liabilities as at September 30, 2019. The Board Meeting was commenced at 4:00 P.M and concluded at 5:15 P.M. (As Per BSE Announcement Dated on 14/11/2019)